Pharmacological inhibition of the ataxia telangiectasia and Rad3-connected protein serine/threonine kinase (ATR; also called FRAP-associated protein (FRP1)) has emerged to be a promising strategy for cancer treatment that exploits synthetic lethal interactions with proteins linked to DNA destruction fix, overcomes resistance to other therapies and improves antitumour immunity. Multipl... https://chamforth555vhs8.wikihearsay.com/user